Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-029509

President and CEO bought 20,000 shares at $5.10 ($101,908)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Brady Todd C President and CEO 2019-12-16 Purchase +20,000 $5.10 $101,908 652,216 D: show line 1 in the form
Open-market purchases · 20,000 sh · avg $5.10 · $101,908
Loading xslF345X03/doc4.xml…